OBJECTIVES: We sought to examine the impact of treatment access on HIV stigma in Botswana 3 years after the introduction of a national program of universal access to antiretroviral therapy. METHODS: We studied the prevalence and correlates of HIV stigma in a population-based study of 1268 adults in Botswana in 2004. We used multivariate logistic regression to assess correlates of stigmatizing attitudes and a new measure, anticipated HIV stigma. RESULTS: Overall, 38% of participants had at least 1 stigmatizing attitude: 23% would not buy food from a shopkeeper with HIV; 5% would not care for a relative with HIV. Seventy percent reported at least 1 measure of anticipated stigma: 54% anticipated ostracism after testing positive for HIV, and 31% anticipated mistreatment at work. Perceived access to antiretroviral therapy was strongly and independently associated with decreased odds of holding stigmatizing attitudes (adjusted odds ratio [AOR] = 0.42; 95% confidence interval [CI] = 0.24, 0.74) and of anticipated stigma (AOR = 0.09; 95% CI = 0.03, 0.30). CONCLUSIONS: Our findings suggest that antiretroviral therapy access may be a factor in reducing HIV stigma. Nevertheless, the persistence of stigmatizing attitudes and significant anticipated stigma suggest that HIV stigma must be a target for ongoing intervention.
OBJECTIVES: We sought to examine the impact of treatment access on HIV stigma in Botswana 3 years after the introduction of a national program of universal access to antiretroviral therapy. METHODS: We studied the prevalence and correlates of HIV stigma in a population-based study of 1268 adults in Botswana in 2004. We used multivariate logistic regression to assess correlates of stigmatizing attitudes and a new measure, anticipated HIV stigma. RESULTS: Overall, 38% of participants had at least 1 stigmatizing attitude: 23% would not buy food from a shopkeeper with HIV; 5% would not care for a relative with HIV. Seventy percent reported at least 1 measure of anticipated stigma: 54% anticipated ostracism after testing positive for HIV, and 31% anticipated mistreatment at work. Perceived access to antiretroviral therapy was strongly and independently associated with decreased odds of holding stigmatizing attitudes (adjusted odds ratio [AOR] = 0.42; 95% confidence interval [CI] = 0.24, 0.74) and of anticipated stigma (AOR = 0.09; 95% CI = 0.03, 0.30). CONCLUSIONS: Our findings suggest that antiretroviral therapy access may be a factor in reducing HIV stigma. Nevertheless, the persistence of stigmatizing attitudes and significant anticipated stigma suggest that HIV stigma must be a target for ongoing intervention.
Authors: Sae Takada; Viola Nyakato; Akihiro Nishi; A James O'Malley; Bernard Kakuhikire; Jessica M Perkins; David R Bangsberg; Nicholas A Christakis; Alexander C Tsai Journal: Soc Sci Med Date: 2019-05-20 Impact factor: 4.634
Authors: Alexander C Tsai; David R Bangsberg; Nneka Emenyonu; Jude K Senkungu; Jeffrey N Martin; Sheri D Weiser Journal: Soc Sci Med Date: 2011-10-10 Impact factor: 4.634
Authors: Sabina A Haberlen; Gertrude Nakigozi; Ronald H Gray; Heena Brahmbhatt; Joseph Ssekasanvu; David Serwadda; Fred Nalugoda; Joseph Kagaayi; Maria J Wawer Journal: J Acquir Immune Defic Syndr Date: 2015-06-01 Impact factor: 3.731
Authors: Brian T Chan; Sheri D Weiser; Yap Boum; Mark J Siedner; A Rain Mocello; Jessica E Haberer; Peter W Hunt; Jeffrey N Martin; Kenneth H Mayer; David R Bangsberg; Alexander C Tsai Journal: AIDS Date: 2015-01-02 Impact factor: 4.177
Authors: Alexander C Tsai; Sheri D Weiser; Wayne T Steward; Nozmo F B Mukiibi; Annet Kawuma; Annet Kembabazi; Conrad Muzoora; Peter W Hunt; Jeffrey N Martin; David R Bangsberg Journal: AIDS Behav Date: 2013-01
Authors: Sae Takada; Sheri D Weiser; Elias Kumbakumba; Conrad Muzoora; Jeffrey N Martin; Peter W Hunt; Jessica E Haberer; Annet Kawuma; David R Bangsberg; Alexander C Tsai Journal: Ann Behav Med Date: 2014-08